FDA Issues Updated Guidance for PROs in Cancer Trials,

The non-binding recommendations were developed by the Oncology Center of Excellence (OCE), Center for Drug Evaluation and Research (CDER), …, The non-binding recommendations were developed by the Oncology Center of Excellence (OCE), Center for Drug Evaluation and Research (CDER), …, Read More

Scroll to Top